Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Has results × gimeracil × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

Carboplatin 154 Cisplatin 151 Paclitaxel 150 Docetaxel 117 Cyclophosphamide 114 Dexamethasone 100 Doxorubicin 95 Bevacizumab 90 Gemcitabine 89 pembrolizumab 88 Prednisone 84 Rituximab 82 Fluorouracil 69 Pemetrexed 66 Vincristine 65 Radiotherapy 64 Etoposide 64 Nivolumab 59 Leucovorin 56 Capecitabine 55 Trastuzumab 53 Cytarabine 51 Methotrexate 43 Oxaliplatin 39 atezolizumab 37 Lenalidomide 37 Filgrastim 36 Irinotecan 34 Bortezomib 33 Sorafenib 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01515748 2023-12-13

PRODIGY

Sanofi

Phase 3 Completed

530 enrolled 11 charts

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡